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The metabolism of dietary proteins generates waste products that are excreted by the 
kidney, in particular nitrogen-containing urea, uric acid, ammonia, creatinine, and other 
metabolites such as phosphates, sulfates, and protons. Kidney adaptation includes an 
increase in renal plasma flow (RPF) and glomerular filtration rate (GFR) and represents a 
burden for diseased kidneys increasing the progression rate of CKD. The present study 
aimed at identifying potential differences between amino acid (AA) groups constituting 
dietary proteins regarding their impact on RPF, GFR, and CKD progression. We utilized 
the well-established 5/6 nephrectomy (5/6 Nx) CKD model in rats and submitted the 
animals for 5 weeks to either the control diet (18% casein protein) or to diets containing 
8% casein supplemented with 10% of a mix of free amino acids, representing all or only 
a subset of the amino acids contained in casein. Whereas the RPF and GFR measured 
in free moving animals remained stable during the course of the diet in rats receiving the 
control mix, these parameters decreased in animals receiving the branched chain amino 
acid (BCAA) supplementation and increased in the ones receiving the aromatic amino 
acids (AAAs). In animals receiving essential amino acids (EAAs) containing both BCAAs 
and AAAs, there was only a small increase in RPF. The kidneys of the 5/6 Nx rats receiving 
the BCAA diet showed the strongest increase in smooth muscle actin and collagen mRNA 
expression as a result of higher level of inflammation and fibrosis. These animals receiving 
BCAAs also showed an increase in plasma free fatty acids pointing to a problem at the 
level of energy metabolism. In contrast, the animals under AAA diet showed an activation 
of AMPK and STAT3. Taken together, our results demonstrate that subsets of EAAs 
contained in dietary proteins, specifically BCAAs and AAAs, exert contrasting effects on 
kidney functional parameters and CKD progression.
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INTRODUCTION
A high dietary protein load increases both renal plasma flow 
(RPF) and glomerular filtration rate (GFR) acutely and in the 
long term, and increases renal expression of proinflammatory 
genes (Hostetter et al., 1986; Tovar-Palacio et al., 2011; Juraschek 
et al., 2013). In the case of Dahl salt-sensitive rats, high protein 
diet has been shown to increase immune cell infiltration of 
kidneys, blood pressure, and kidney damage (De Miguel et  al., 
2011). As early as 1948, a restriction of protein intake has 
been suggested to prevent the increase in “workload” of surviving 
nephrons in patients with chronic kidney disease (CKD) (Brenner 
et  al., 1982). Importantly, recent studies confirm the utility of 
restricting protein intake in CKD patients to slow down CKD 
progression (Koppe and Fouque, 2019).
Interestingly, not all proteins equally induce hyperfiltration 
and some of their constituent AAs, for instance, branched 
chain amino acids (BCAAs) appear to be  less effective than 
others (Claris-Appiani et  al., 1988). There is however a lack 
of recent studies investigating underlying mechanisms (Alvestrand 
and Bergstrom, 1984; Friedlander et  al., 1990; Luippold et  al., 
2004, 2006). Nonetheless, it appears crucial that renal adaptation 
to protein intake, including hyperfiltration, is necessary for 
the excretion of the nitrogenous end products (urea, ammonia, 
etc.) and other protein-associated wastes including acid 
equivalents due to the metabolism of sulfur-containing and 
cationic amino acids. This adaptation involves the combined 
effects of the hormones vasopressin and glucagon that together 
contribute to efficient urea excretion and water economy (Bankir 
et  al., 2015, 2018). Furthermore, handling of the acid load 
from proteins of animal origin is considered to contribute to 
accelerated CKD progression (Scialla and Anderson, 2013).
Besides the smaller effect of BCAAs on hyperfiltration and 
the potentially more harmful effect of sulfur-containing and 
cationic amino acids due to acid production, it is not known 
whether specific amino acid groups may differentially affect 
kidney function and CKD progression.
To test the potential differential effects of various amino 
acid groups on CKD progression, we  chose to use the well-
established 5/6 nephrectomy (5/6 Nx) model that corresponds 
to the situation of a reduced number of nephrons in the 
absence of specific glomerular or tubular lesions (Lim et  al., 
2014). To assess the kidney function repeatedly in these rats 
in awake condition, we  measured the GFR using the 
transcutaneous FITC-sinistrin concentration-decay curve method 
(Scarfe et  al., 2018). For measuring renal plasma flow, 
we  developed a technique that allowed us to measure the 
clearance of exogenous PAH applied while rats were awake. 
This was however only possible to perform at the end of the 
experiment. Practically, radioactive PAH was released by an 
osmotic mini pump and its urinary excretion measured over 
24  h in a metabolic cage. Its renal extraction from arterial 
blood was then determined by measuring its concentration in 
arterial and renal venous blood at the end of the urine collection, 
after sacrificing the rat.
The diets enriched in different amino acid groups given 
to the rats were based on the usual laboratory rat diet 
(AIN93) and contained all 18% caloric content as protein 
and amino acids. Eight percent (minimal dietary protein 
caloric fraction for rats; Meireles et  al., 1999) of these was 
given as casein and the other 10% as free amino acids. 
These amino acid mixes had the same relative concentration 
as in casein, either of all amino acids (8  +  10), or only of 
a subset of them, namely the non-essential ones (NEAAs), 
the essential ones (EAAs), the branched chain ones (BCAAs), 
or the aromatic ones (AAAs). Submitting 5/6 Nx rats to 
these diets, we  could demonstrate that the amino acid 
composition of the proteinaceous part of the diet differentially 
affects CKD progression.
METHODS
Animals
Experiments were performed with male 250- to 300-g 
(10–12  weeks old) Wistar Han rats purchased from Charles 
River (Germany). All procedures for rat handling and 
experimental interventions were performed in accordance with 
Swiss Animal Welfare laws and approved by the Cantonal 
Veterinary Office, Zürich. Rats were group-housed in standard 
laboratory conditions with a 12-h light/dark cycle. They had 
free access to food and water.
Diets
Rats were fed with the maintenance diet containing 18% protein 
(2222 Granovit, Switzerland) during acclimatization and 4 weeks 
after the surgery. At week 4, GFR was measured and the 
animals were then shifted for the end of the experiment to 
modified diets as described below and on which they remained 
for the rest of the experiment. The modified diets (variants 
of 2222, Granovit, Switzerland) were designed to contain 8% 
protein and 10% amino acid mix in the same proportion as 
that found in casein (Supplementary Table S4). Thus, for all 
diets, the AAs not part of the AA mix (only present in the 
8% casein) were present at 44.5% of their level in an 18% 
casein diet and in the 8  +  10 diet. In the case of the NEAA 
diet (11 non-essential amino acids in the 10% AA mix: Ala, 
Arg, Asn, Asp, Cys, Gln, Glu, Gly, Pro, Ser, Tyr), each of the 
11 NEAAS was present in total (in casein  +  AA mix) at a 
level representing 146% of what the pure casein diet (18% of 
calories) and the 8  +  10 diet contained. In the case of the 
EAA diet (nine EAAs: His, Ile, Leu, Lys, Met, Phe, Thr, Trp, 
Val), their total concentration was 167% of the concentration 
present in the casein and the 8  +  10 diets. In the case of the 
BCAA and the AAA diets (each only three AAs; BCAAs: Ile, 
Leu, Val; AAAs: Phe, Trp, Tyr), the proportion of these AAs 
was 450% of their concentration in the 18% casein or the 
8  +  10 diets. The study is based on four experimental series 
and the results of identical groups have been pooled. Due to 
the lack of change in our readouts, some dietary groups were 
not repeated. Therefore and because not all measurements have 
been performed in all experimental series, the numbers vary 
between the different groups and determinations.
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Surgeries
The experiments were started after at least 1  week of 
acclimatization. For the surgery, rats were shortly anesthetized 
with isoflurane. The UNX was performed first on the right 
kidney and the 2/3 Nx (second surgery) was performed a 
week later on the left kidney. The area undergoing the surgery 
was shaved the day before, in case of both operations. For 
the UNX, an incision was made on the right side. The adrenal 
was carefully separated from the upper pole of the kidney 
before ligating the renal pedicle. The right kidney was then 
removed and the peritoneum and the skin sutured. The animals 
were allowed to recover for 1  week prior to performing the 
2/3 Nx. Under isoflurane anesthesia, the left kidney was exposed 
and the adrenal separated before the two poles of the kidney 
were amputated and covered with gel foam (Spongostan, Ethicon, 
USA) as described (Van Koppen et  al., 2013).
For sham surgeries, the same process was followed on both 
the left and right sides with a 1-week gap between surgeries. 
In both cases, the kidneys were exposed but not ablated.
Glomerular Filtration Rate Measurements
Rats were shaved the evening prior to measurement. On the 
day of the measurement, the rats were briefly anesthetized 
with 1.5% isoflurane and the transcutaneous GFR measurement 
camera (Medibeacon, Germany) was attached via a sticky patch 
and surgical tape to the rat. FITC-sinistrin (Fresenius Kabi, 
Germany) at a concentration of 7  mg/100  g body weight was 
injected via the tail vein. The rat was allowed to wake up 
and placed alone in a cage for 2  h. Following this, the camera 
was removed from the rat, the rat returned to the home cage, 
and the measurement from the camera analyzed using MPD 
studio (Medibeacon, Germany).
Renal Plasma Flow Measurements
RPF measurements were performed as terminal experiments 
in most animals in which GFR had been previously tested. 
An osmotic pump (2ML1 Charles River, Germany) containing 
a solution of [3H] PAH (Perkin Elmer, USA) and 10  μM 
unlabeled PAH (with HEPES as a buffer) in saline was implanted 
into the rat that was put into the metabolic cage for 24  h. 
The following day, food was taken away for 1  h before the 
animal was anesthetized (3% isoflurane), and blood was collected 
from both the renal vein and the aorta for RPF calculations. 
The urine collected in the metabolic cage provided the 
information for urinary flow rate and urinary tracer 
measurements. Tubes were prepared containing either 100  μl 
of plasma or 100  μl of urine. A volume of 3  ml of ultimate 
GoldTM scintillation fluid (Perkin Elmer, Waltham, MA, USA) 
was added and the tubes were shaken for 2  h following which 
the level of radioactivity was measured using the liquid 
scintillation analyzer (Packard Tri-Carb 2900TR, PerkinElmer, 
USA). The RPF was then calculated by using the formula RPF 
(ml/min) = (U*V)/(Pa − Pv) where U is the urinary concentration 
of [3H] PAH, V is the urinary flow rate in ml/min, Pa is the 
arterial plasma concentration of [3H] PAH, and Pv is the venous 
plasma concentration of [3H] PAH.
Body Composition Measurements
Measurements were performed using the ECHO-MRI (ECHO 
Medical Systems, USA). Calibrations and measurements were 
performed according to manufacturer’s instructions.
Ultra-Performance Liquid Chromatography 
Amino Acid Measurements
Amino acid concentration analysis was performed at the 
Functional Genomic Centre Zurich (FGCZ), using the Mass 
Track Amino Acid Analysis Application Solution by ACQUITY 
ultra-performance liquid chromatograph (UPLC; Waters 
Corporation, Milford MA, USA) according to the 
manufacturer’s instructions. Plasma samples were diluted to 
1:1 with 10% sulfosalicylic acid for deproteinization prior 
to UPLC.
Measurement of Free Fatty Acids, 
Creatinine, and Electrolytes
FFA were measured using the ASC-ACOD Method (a 
colorimetric assay) following the manufacturer’s instructions 
(Fujifilm Wako, Germany). Measurements of sodium, potassium, 
magnesium, chloride, calcium, phosphorous, urea, and 
creatinine were done on UniCel DxC 800 Synchron Clinical 
System (Beckman Coulter), a service provided by the Zürich 
Integrative Rodent Physiology (ZIRP) facility following the 
manufacturer’s instructions.
Quantitative Real-Time Polymerase  
Chain Reaction
Tissue samples were lysed using Trizol (Ambion, Thermo Fisher 
Waltham, MA, USA) with a Precellys homogenizer (Bertin 
instruments, Montigny-le-Bretonneux, France). Total RNA was 
extracted using the RNeasy mini kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions. RNA concentration 
was determined using a Nanodrop (Agilent Technologies, Santa 
Clara, CA, USA) and 500  ng was used to synthesize single-
strand cDNA in 20  μl reactions using the qScript cDNA 
Synthesis Kit (Quanta Biosciences, Beverly, MA, USA). The 
values were expressed relative to GAPDH (2∆Ct).
Quantitative polymerase chain reaction (qPCR) primers were 
either based on previously reported sequences (Ding et  al., 
2012; Dizin et  al., 2013) or designed using the NCBI primer 
blast tool.1 The primers used were as follows: GAPDH forward 
5′-GCAAGAGAGAGGCCCTCAG-3′ and GAPDH reverse 
5′-TGTGAGGGAGATGCTCAGTG-3′, α-SMA forward 5′-AC 
TGAGCGTGGCTATTCCTT-3′ and reverse 5′-TTCTCCAGG 
GAAGAAGAGGA-3′, COL1A1 forward 5′-ATCTCCTGGTG 
CTGATGGAC-3′ and reverse 5′-ACCTTGTTTGCCAGGTT 
CAC-3′, COL1A2 forward 5′-CCCCAAAACGTTTGCAGTGT-3′ 
and reverse 5′-GACAATGTCCACAACAGGTGTC-3′, COL3A1 
forward 5′-CCCCAAAACGTTTGCAGTGT-3 and reverse 5′-G 
ACAATGTCCACAACAGGTGTC-3′. qPCR was performed in 
a 96-well format and consisted of 2  μl of diluted cDNA per 
1 http://www.ncbi.nlm.nih.gov/tools/primer-blast/
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well, PowerUp SYBR Green Mastermix (Applied Biosystems, 
Foster City, CA, USA) and 0.5  μM of each primer in a 20  μl 
reaction. Thermal cycling conditions were an initial denaturation 
step of 94°C for 2  min, and then 40  cycles of 94°C for 15  s 
and 57°C for 1  min. Each experimental cDNA was measured 
in triplicate.
Western Blot
Samples were homogenized with beads (Roche, cat#03358941001) 
at 6,000  rpm for 30  s in a mannitol-based resuspension buffer 
(200  mM D-Mannitol, 80  mM HEPES, 41  mM KOH, pH 
7.5, 0.8% NP40) supplemented with protease and phosphatase 
inhibitor cocktails in a Precellys 24 device (France). The 
homogenate was then centrifuged at 2,000  g for 15  min at 
4°C to sediment cellular debris. Supernatant was ultracentrifuged 
at 41,000  rpm for 10  min at 4°C (rotor RP45A, Sorvall, 
ThermoFisher Scientific, Waltham, MA, USA) to eliminate 
small debris. Protein concentration was determined using 
Pierce™ BCA Protein Assay (Cat#23228, Lot#UA269551, 
ThermoFischer Scientific, Rockford, IL, USA) according to the 
manufacturer’s instructions.
Phospho and total AMPK, phospho and total STAT3, α-SMA, 
β-tubulin antibodies used for western blotting were purchased 
from CST (USA). The blots were performed according to 
manufacturer’s instructions. When anti-phospho and total protein 
antibodies were used, first the phospho proteins were imaged 
using the corresponding antibody and HRP staining. Then, 
the membrane was stripped using the Abcam (Germany) harsh 
stripping protocol that includes β-mercaptoethanol. Finally, the 
total proteins were visualized on the same blot by using AP 
(Millipore, Switzerland). Chemiluminescence was detected with 
a LAS-4000 camera system (Fujifilm). Densitometric analysis 
was performed using ImageJ.
Microscopy, Immunohistochemistry,  
and Quantification
Remnant left kidneys that had undergone partial nephrectomy 
were removed, sliced, and fixed in 10% neutral-buffered formalin 
(Formafox, Hittmau, Switzerland), followed by dehydration 
through graded alcohols and embedding in paraffin wax. 
Consecutive sections (3–5  μm) were prepared, mounted on 
glass slides, and subjected to hematoxylin and eosin (HE) 
staining. Immunohistochemistry for the detection of alpha 
smooth muscle actin (α SMA) was carried out on the renal 
sections using an antibody against alpha-smooth muscle actin 
(clone 1A4; DAKO, Basel, Switzerland) in a Dako Autostainer 
(Dako Autostainer Universal Staining System Model LV-1, 
Dako-Agilent Technologies). All slides were scanned using a 
digital slide scanner (NanoZoomer-XR C12000; Hamamatsu, 
Japan) and histomorphometrical analysis was performed on 
the digital slides using the Visiopharm Integrator System (VIS, 
version 4.5.1.324, Visiopharm, Hørsholm, Denmark). α-SMA-
positive areas were quantified in each animal using at least 
40 fields per kidney section, avoiding regions containing large 
α-SMA-positive vessels. Results were expressed as average 
fraction of α-SMA-positive areas normalized against the total 
renal parenchyma.
Statistical Analysis
GraphPad Prism software (version 6; GraphPad Software Inc., 
San Diego, CA) was used to perform statistical analysis. 
Differences between groups were determined by Student’s t-test 
for two groups (paired in case the same animal was being 
followed over time) or one-way repeated-measures ANOVA 
for ≥3 groups with a Dunnett post hoc test versus a control 
group. Values are presented as means ± SEM and were considered 
different when p  <  0.05.
RESULTS
To test whether the amino acid composition of dietary proteins 
was important in the progression of CKD, we  designed an 
experimental protocol using 5/6 nephrectomy (5/6 Nx) as 
CKD model in rats. After 6  weeks on normal control diet 
(CD) containing 18% casein (Figure 1A), we submitted these 
animals to different isocaloric diets containing 8% protein, 
supplemented with 10% of an amino acid mix containing 
one of the following: all amino acids as in casein (8  +  10), 
branched chain amino acids (BCAAs), aromatic amino acids 
(AAAs), essential amino acids (EAAs), or non-essential amino 
acids (NEAAs). Using the FITC-sinistrin clearance technique, 
GFR was measured before the first surgery and again in 5/6 
Nx (CKD model) animals 4  weeks after the second surgery 
(Figure 1A). The second measurement showed that GFR had 
decreased as expected by more than 50%, namely from 
1.5 ± 0.06 ml/min/100 g BW before surgery to 0.6 ± 0.04 ml/
min/100  g BW after 5/6 Nx (Figure 1B, p  <  0.005). The 
animals were then randomly assigned to the different diet 
groups and the GFR was measured again after 2 and 5 weeks 
of diet (at weeks 6 and 9) (Figure 1B). Interestingly only 
the BCAA group showed a significant decrease in GFR over 
this period, namely from 0.7  ±  0.03  ml/min/100  g BW at 
week 4 to 0.52 ± 0.02 ml/min/100 g BW at week 9 (p < 0.05). 
In contrast, the AAA group showed the opposite effect with 
GFR increasing from 0.63  ±  0.03  ml/min/100  g BW at week 
4 to 0.72  ±  0.05  ml/min/100  g BW at week 9 (p  <  0.05).
RPF was measured in rats 9  weeks post second surgery. 
Similar to GFR, we  observed a reduction in the case of 
BCAA diet (1.55  ±  0.26  ml/min/100  g BW) (Figure 1C) 
compared with the 8  +  10 group (1.93  ±  0.25  ml/min/100  g 
BW, p  <  0.05) and a strong increase in RPF for the AAA 
diet group (4.61  ±  0.45  ml/min/100  g BW, p  <  0.01) and 
to a lesser extent for the EAA group (3.17 ± 0.21 ml/min/100 g 
BW, p  <  0.05). Interestingly, the EAAs that contained both 
the AAAs and the BCAAs produced an effect resembling 
more that of AAAs. There were no changes in the GFR 
and RPF of sham-operated animals on different diets 
(Supplementary Tables S1, S2). Additionally, no significant 
changes were observed between animal groups in terms of 
body weight, food and water consumption, urinary output 
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and proteinuria. The fractional excretion of the tested 
electrolytes was comparable across the different diets with 
the exception of phosphorous, which was decreased in the 
BCAA group (Table 1).
We also evaluated the body composition of the different 
animal groups using ECHO MRI (Figure 2). The CKD-AAA 
animals showed a significant reduction in fat (p < 0.05) whereas 
the sham-operated AAA animals also showed a reduction in 
fat, albeit not statistically significant. This suggests that the fat 
decrease was induced by the AAA diet, with little influence 
of CKD. Note that the BCAA-CKD group showed a 
non-significant increase in fat (p  =  0.06). This effect was 
observed only in the CKD group and not in the sham-
operated animals.
We investigated the impact of the different diets on kidney 
morphology and fibrosis first by visualizing its structure 
on hematoxylin and eosin (HE)-stained sections (Figure 3A). 
Kidney sections from 5/6 Nx animals exhibited glomerular 
hypertrophy with mesangial matrix expansion, consistent 
with CKD injury described in this model. However, no 
A
B
C
FIGURE 1 | Impact of amino acid diets on GFR and RPF. (A) Schematic representation of experimental plan. CD stands for control diet (18% casein), 8 + 10 for 
8% casein +10% casein amino acid mix, BCAA, AAA, EAA, and NEAA for 8% casein +10% of branched chain, aromatic, essential, and non-essential amino acid 
mix, respectively. (B) Impact of 5/6 nephrectomy (5/6 Nx) on GFR measured in free moving animals. The GFR was measured a first time before first surgery 
(uninephrectomy) (BS) and again 4 weeks after the second surgery just before starting the diet (4). The animals were then given different diets as indicated in the 
boxes below the X axis. GFR was measured again 2 and 5 weeks after the start of the diet (weeks 6 and 9). 5/6 Nx animals under BCAA diet showed a further 
decrease in GFR (green) and those under AAA diet an improvement (blue) compared to values at week 4. ###p < 0.005 (comparing values at week 4 to those before 
surgery with a paired t test), *p < 0.05 (ANOVA with a Dunnett post hoc test). CD, n = 10; 8 + 10, n = 30; BCAA, n = 25; AAA, n = 25; EAA, n = 15; and NEAA, 
n = 10. (C) Impact of different diets on RPF in CKD animals (5/6 Nx). RPF was measured 5 weeks after starting the diet (week 9). The BCAA group (green) showed a 
decrease in RPF, whereas both the EAA and the AAA (blue) groups showed an increase compared to the 8 + 10 group (black). *p < 0.05; **p < 0.01; CD, n = 7; 
8 + 10, n = 18; BCAA, n = 18; AAA, n = 18; EAA, n = 7; and NEAA, n = 7.
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notable differences were observed between the different 
dietary groups. We  then specifically evaluated α SMA and 
collagen levels, since they represent reliable indicators of 
the progression of CKD. The mRNA expression level of 
both α SMA and collagen (collagen 1A1, 1A2, and 3A1) 
was increased at least two-fold in CKD animals relative to 
A
B
FIGURE 2 | Effect of amino acid supplementation on body composition of CKD and Sham animals. CKD and Sham animals on different diets did not show 
changes in fat (black bars) and lean mass (gray bars for CKD animals and white for controls) with the exception of the AAA groups. They showed a reduction in fat 
mass that was significant in CKD (*p < 0.05) and with a p slightly above the 0.05 limit for the sham group, p = 0.06, ANOVA with Dunnett post hoc test. CKD: CD, 
n = 10; 8 + 10, n = 30; BCAA, n = 25; AAA, n = 25; EAA, n = 15; and NEAA, n = 10. Sham: n = 5 animals per group.
TABLE 1 | Effect of amino acid supplementation on general parameters and fractional excretion (FE) of electrolytes and urea.
8 + 10 BCAA AAA
Mean SEM Mean SEM Mean SEM
Body weight (g) 345.6 7.3 336.8 11.9 342.0 11.5
Food/24 h (g) 14.7 1.5 15.6 1.2 15.2 2.5
Water/24 h (g) 35.3 6.0 30.6 1.9 27.9 2.3
Urine/24 h (ml) 14.6 2.2 14.4 0.8 12.4 2.2
Proteinuria/24 h (mg) 52.2 4.1 54.1 7.9 54.1 7.0
Feces/24 h (g) 1.4 0.6 1.0 0.6 1.0 0.2
Fractional excretion (%)
Na+ 0.2 0.0 0.1 0.0 0.2 0.0
K+ 14.6 1.0 11.0 1.3 12.9 1.7
Cl− 0.6 0.0 0.5 0.1 0.4 0.0
Ca2+ 0.7 0.1 0.7 0.1 0.4 0.1
Mg2+ 6.8 2.1 5.0 1.1 8.9 1.8
Pi 5.1 0.8 1.4* 0.8 5.7 1.8
Urea 57.0 2.1 50.7 2.8 53.3 4.5
*p < 0.05, compared to 8 + 10 CKD group, n = 10 animals per group.
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sham-operated ones (on 8  +  10 diet) (Figure 3B). Within 
the CKD animals, the BCAA group showed, compared with 
the 8  +  10 group, a significant increase in the expression 
of all three tested collagens [1A1 (p < 0.005), 1A2 (p < 0.05), 
and 3A1 (p  <  0.05)] as well as α SMA (p  <  0.05) compared 
with the 8  +  10 group.
To study the expression of α SMA at the protein level, 
we performed both western blots (Figures 3C,D) and quantitative 
immunohistochemical analysis (Figures 3E,F). Both methods 
also showed significantly increased levels of α SMA only in 
the BCAA group relative to the 8  +  10 one (p  <  0.05 and 
<0.01, respectively).
A B
E
D
F
C
FIGURE 3 | Impact of amino acid diets on fibrosis markers. (A) Hematoxylin-eosin labeled kidney sections of 5/6 Nx and sham-operated rats. Kidneys of 5/6 Nx 
animals show hallmarks of CKD including glomerular hypertrophy and mesangial matrix expansion, unlike sham-operated animals. (B) mRNA of α SMA and collagen 
in CKD and sham-operated animals on different diets. A significant increase in α SMA, COL1A1, COL1A2, and COL3A1 mRNAs was observed in CKD versus 
sham-operated animals on 8 + 10 diet. #p < 0.05, ##p < 0.05. Among CKD animals, there was no difference between AAA and 8 + 10 diets, whereas all mRNAs 
were significantly increased under BCAA diet. *p < 0.05, ***p < 0.001, ANOVA with Dunnett post hoc test n = 10. (C–F) Protein levels of α SMA measured by 
western blot (C,D) and visualized by microscopy (E,F). α SMA levels were increased only in the BCAA group. The reason for α SMA fragmentation seen on western 
blot specifically in AAA samples is not known. Representative blots and sections are shown. *p < 0.05, **p < 0.01, ANOVA with Dunnett post hoc test. 8 + 10, 
n = 8, BCAA and AAA, n = 6.
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Furthermore, we tested the plasma amino acid concentration, 
which has been shown by others to vary depending on the 
progression of CKD (Duranton et  al., 2014). Interestingly, the 
BCAAs and AAAs that were highly enriched in the corresponding 
diets, tended to be lower in the plasma of the respective groups 
as measured during the resting phase (1 h after food removal). 
However, these potential changes were not statistically significant 
compared to the 8 + 10 control group (Supplementary Table S3).
Recent studies have identified markers of tubular overload 
and attempted to elucidate the mechanisms by which such 
functional overload and consecutive damage lead to interstitial 
fibrosis as observed in CKD. One of the important signaling 
pathways activated by functional overload is that of AMP-activated 
protein kinase (AMPK). Interestingly, this pathway was repressed 
in the remnant kidney of CKD animals under BCAA diet 
(decreased phospho−/total AMPK ratio) whereas it was activated 
in that of the AAA diet group (increased phospho−/total AMPK 
ratio) (Figures 4A,C, p < 0.05). STAT3 has emerged as a major 
mediator of tubulointerstitial cross talk in CKD (Bienaime et al., 
2016). Parallel to the situation with AMPK, we  noted in our 
experiments that phospho/total STAT3 was reduced in kidneys 
of CKD animals under BCAA diet, whereas it was increased 
in the kidney of rats under AAA diet compared to the 8  +  10 
group (Figures 4A,B). An intriguing observation is the apparent 
increase in total STAT3 and AMPK protein under AAA diet 
that is well visible in comparison with beta-actin (Figure 4A). 
This apparent increase in AMPK and STAT3 protein expression 
level adds up to the increased proportion of their phosphorylated 
forms and might point to an additional mechanism by which 
the AAA dietary load acts.
We measured plasma free fatty acids because of the rapid 
deleterious effect of the BCAA diet in CKD and since 
branched chain amino acid metabolism is known to feed 
into β-oxidation and citric acid cycle and thus to compete 
A B
C D
FIGURE 4 | Impact of CKD and amino acid diets on renal pSTAT3 and pAMPK and on plasma free fatty acids (FFA). (A) Western blot. Total and phosphorylated 
STAT3 appear as two bands of approximately 79 and 86 kD and AMPK as one band around 62 kDa. Both are possibly decreased under BCAA diet and clearly 
increased under AAA diet. (B) Quantitation of pSTAT3/STAT3 phosphorylation ratio (n = 5), *p < 0.05 compared to 8 + 10 animals. (C) Quantitation of pAMPK/
AMPK phosphorylation ratio (n = 5), *p < 0.05 compared to 8 + 10 animals. (D) Plasma free fatty acids. There is no difference between CKD and control animals 
under 8 + 10 and AAA diets. The FFA are, however, elevated in CKD animals under BCAA diet. *,#p < 0.05 comparing to CKD and Sham animals, respectively, both 
under 8 + 10 diet (ANOVA with Dunnett post hoc test). Sham, n = 5; CKD, n = 8 animals per group.
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with fatty acid metabolism (Newgard, 2012). We  found their 
level was indeed elevated specifically in the CKD group 
with BCAA diet (Figure 4D, p  <  0.05).
DISCUSSION
This study shows that the administration of dietary proteins 
containing different proportions of specific amino acid groups 
differentially impacts on CKD progression. Differences between 
the groups became visible already 2  weeks after initiation of 
the diet. In particular, the BCAA group showed a further 
decrease in GFR and the AAA group an increase. These changes 
in GFR were parallel to changes in RPF. Surprisingly, the EAA 
group receiving a diet containing an increased proportion of 
both BCAAs and AAAs also showed an increase in RPF, more 
similar to the AAA than the BCAA group.
The AAA group rats had a smoother body texture and 
interestingly this difference correlated with a lower proportion 
of fat measured by ECHO MRI (Figure 2). However, there 
were no other gross morphological differences observed between 
sham-operated rats and the different CKD groups. At the level 
of the kidneys, all CKD animals typically showed glomerular 
hypertrophy, mesangial expansion, and increased markers of 
fibrosis such as α SMA and collagen (Figures 3A,B; Gava et  al., 
2012; Lim et al., 2014). The BCAA diet group showed, compared 
to the CKD 8  +  10 and the AAA groups, a significant further 
increase in both fibrosis markers (Figures 3B–F). In a search 
for possible mediators, we tested tubular STAT3 that has recently 
emerged as an important mediator of the tubulointerstitial cross 
talk that leads to interstitial fibrosis in CKD (Bienaime et  al., 
2016). Surprisingly, the kidney of the more affected BCAA group 
showed a decrease in phospho/total STAT3 ratio whereas the 
apparently protected AAA group showed an increase. A possible 
explanation is that the BCAA animals had already passed the 
stage of elevated pSTAT3 expression at the time of the measurement 
(5-week diet), whereas the AAA group had first developed an 
increased plasma flow and GFR and correspondingly experienced 
an additional functional overload leading to an activation of 
the AMPK pathway. It may be that the activation of this pathway, 
which lies at the crossroads of energy metabolism, ion transport, 
and inflammation, has exerted a protective effect in the kidney 
of the AAA group (Rajani et  al., 2017). However, it has not 
been established why the AAA-rich diet affected the RPF and 
correspondingly the GFR specifically in CKD conditions. It has 
to be mentioned that the GFR increase was proportionally smaller 
than that of the RPF, indicating a decrease in fractional filtration 
and suggesting a dilation of both vasa afferentia and efferentia. 
We  might speculate that the high amount of dietary aromatic 
amino acids led to an increase in the production of (vasoactive) 
catecholamines and/or tryptophan derivatives in the AAA group. 
These mediators could have led not only to the decrease in fat 
observed also in sham-operated animals, but also to an increase 
in RPF specifically in the 5/6 Nx CKD model in which the 
tubuloglomerular feedback is known to be  inoperative (Singh 
et  al., 2012). Thus, after 5  weeks of high-aromatic amino acid 
diet, the functional strain due to increased RPF and GFR 
presumably started to cause deleterious effects as suggested by 
the elevated expression and activation of STAT3. This effect is 
in agreement with earlier observations showing that a long-term 
exposure to a high-protein diet causes an increase in GFR but 
that this hyperfiltration may have over time deleterious effects 
(Brenner et  al., 1982; Koppe and Fouque, 2019).
The question of the mechanism leading to the much more 
rapid alteration of the remnant kidney under BCAA diet remains 
to be  elucidated. A hint toward a role of metabolic imbalance 
comes from the observation that plasma free fatty acids were 
elevated and phosphorylated AMPK decreased in the BCAA group 
(Figures 4C,D). This might be  due to the fact that branched 
chain amino acid metabolism feeds into β-oxidation and the citric 
acid cycle and thus competes with fatty acid metabolism (Newgard, 
2012). Additionally, BCAAs have been shown to impact on 
metabolism by modulating PI3K-AKT signaling and its downstream 
transcriptional regulation, in particular of the transcription factor 
KLF15 (Kruppel-like factor 15) (Liu et  al., 2017).
Taken together, we  have shown that amino acids contained 
in the diet, and thus the composition of dietary proteins, have 
a major differential impact on the evolution of CKD in rats. 
Aromatic amino acids (AAAs) and branched chain amino acids 
(BCAAs) are two groups of essential dietary amino acids that 
displayed seemingly opposite effects, at least over a period of 
5  weeks. The AAAs strongly stimulated the RPF and to a 
lesser extent GFR, possibly via an effect on the production 
of bioactive molecules. The BCAAs rapidly interfered with 
renal function, decreasing GFR and stimulating kidney fibrosis, 
thus increasing CKD progression, presumably via their effect 
on energy metabolism. Our results suggest it could be  useful 
to test the administration of dietary proteins containing low 
levels of branched chain amino acids to slow down 
CKD  progression, in addition to restricting their total amount 
(Scialla and Anderson, 2013; Koppe and Fouque, 2019).
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